切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2016, Vol. 05 ›› Issue (01) : 21 -26. doi: 10.3877/cma.j.issn.2095-3224.2016.01.05

所属专题: 文献

青年专家论坛

中期和局部晚期老年直肠癌辅助放化疗进展
刘文扬1, 金晶1,()   
  1. 1. 100021 北京,中国医学科学院 北京协和医学院肿瘤医院放疗科
  • 收稿日期:2016-01-17 出版日期:2016-02-25
  • 通信作者: 金晶
  • 基金资助:
    国家自然科学基金资助项目(81272510)

Treatment advance of (neo) adjuvant chemoradiation for the elderly intermediate and locally advanced rectal cancer patients

Wenyang Liu1, Jing Jin1,()   

  1. 1. Department of Radiotherapy, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China
  • Received:2016-01-17 Published:2016-02-25
  • Corresponding author: Jing Jin
  • About author:
    Corresponding author: Jin Jing, Email:
引用本文:

刘文扬, 金晶. 中期和局部晚期老年直肠癌辅助放化疗进展[J]. 中华结直肠疾病电子杂志, 2016, 05(01): 21-26.

Wenyang Liu, Jing Jin. Treatment advance of (neo) adjuvant chemoradiation for the elderly intermediate and locally advanced rectal cancer patients[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(01): 21-26.

直肠癌是我国及世界范围内最常见的肿瘤之一,其中的高龄患者比例逐年增加。由于缺乏针对高龄患者的前瞻性循证医学证据,目前高龄患者综合治疗的标准方案尚待明确,相当比例的高龄患者并未得到最佳的综合治疗。本文将主要从老年直肠癌的流行病学、治疗模式,尤其是(新)辅助放化疗方面,系统回顾现有资料,探讨中期及局部晚期老年直肠癌的最佳治疗模式。

Rectal cancer is one of the most commonly diagnosed cancers in China and worldwide, with an increasing trend in the proportion of elderly patients. However, as the prospective evidence designed specifically for treating this population is sparse, and the treatment algorithms for these patients become controversial, it is clear that a significant percentage of elderly rectal cancer patients has been treated less than optimally. This paper provides overviews of the recent data on epidemiology, treatment modality, especially (neo) adjuvant chemoradiation in the treatment of older rectal cancer patients, and to discuss the optimal treatment algorithm for the intermediate and locally advanced rectal cancer in the elderly.

[1]
Hurria A, Levit LA, Dale W, et al. Improving the evidence base for treating older adults with cancer: American Society of Clinical Oncology statement. Journal of Clinical Oncology, 2015, 33(32): 3826-3833.
[2]
Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011. Chin J Cancer Res, 2015, 27(1): 2-12.
[3]
Papamichael D, Audisio R, Horiot JC, et al. Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol, 2009, 20(1): 5-16.
[4]
Li M, Gu J. Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol, 2005, 11(30): 4685-4688.
[5]
Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. Jama, 2004, 291(22): 2720-2726.
[6]
Mor V, Masterson-Allen S, Goldberg RJ, et al. Relationship Between Age at Diagnosis and Treatments. Journal of the American Geriatrics Society, 1985, 33(9): 585-589.
[7]
Decoster L, Van Puyvelde K, Mohile S, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendationsdagger. Ann Oncol, 2015, 26(2): 288-300.
[8]
Kunkler IH, Audisio R, Belkacemi Y, et al. Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force. Ann Oncol, 2014, 25(11): 2134-2146.
[9]
Papamichael D, Audisio RA, Glimelius B, et al. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol, 2015, 26(3): 463-476.
[10]
Group, C. C. C. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet, 2000, 356(9234): 968-974.
[11]
Larsen SG, Wiig JN, Tretli S, et al.Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age. Colorectal Dis, 2006, 8(3): 177-185.
[12]
Rutten HJ, den Dulk M, Lemmens VE, et al. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol, 2008, 9(5): 494-501.
[13]
Kiran RP, Attaluri V, Hammel J, et al. A novel nomogram accurately quantifies the risk of mortality in elderly patients undergoing colorectal surgery. Ann Surg, 2013, 257(5): 905-908.
[14]
Townsley C, Pond GR, Peloza B, et al.Analysis of treatment practices for elderly cancer patients in Ontario, Canada. J Clin Oncol, 2005. 23(16): 3802-3810.
[15]
Townsley C, Pond GR, Peloza B, et al. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol, 2005, 55(3): 231-240.
[16]
Fiorica F, Cartei F, Licata A, et al.Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data. Cancer Treat Rev, 2010, 36(7): 539-549.
[17]
Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med, 2006, 355(11): 1114-1123.
[18]
Gérard JP, Conroy T, Bonnetain F,et al.Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol, 2006, 24(28): 4620-4625.
[19]
Sauer R, Becker H, Hohenberger W,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 2004, 351(17): 1731-1740.
[20]
Schmoll HJ, Van Cutsem E, Stein A, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol, 2012, 23(10): 2479-2516.
[21]
Sebag-Montefiore D, Stephens RJ, Steele R, et al.Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet, 2009, 373(9666): 811-820.
[22]
Ngan SY, Burmeister B, Fisher RJ, et al.Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. Journal of Clinical Oncology, 2012, 30(31): 3827-3833.
[23]
Peeters KC, Marijnen CA, Nagtegaal ID,et al.The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Annals of surgery, 2007, 246(5): 693-701.
[24]
Tan E, Tilney H, Thompson M, et al.The United Kingdom National Bowel Cancer Project-epidemiology and surgical risk in the elderly. European Journal of Cancer, 2007, 43(15): 2285-2294.
[25]
Potosky AL, Harlan LC, Kaplan RS, et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol, 2002, 20(5): 1192-1202.
[26]
Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer, 1990, 66(1): 49-55.
[27]
Pignon T, Horiot JC, Bolla M, et al.Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol, 1997, 42(2): 107-120.
[28]
Shahir MA, Lemmens VE, van de Poll-Franse LV, et al.Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer, 2006, 42(17): 3015-3021.
[29]
Rutten H, den Dulk M, Lemmens V, et al. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Eur J Cancer, 2007, 43(15): 2295-2300.
[30]
Maas HA, Lemmens VE, Nijhuis PH, et al. Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75 years and older. Eur J Surg Oncol, 2013, 39(10): 1087-1093.
[31]
Lorchel F, Peignaux K, Créhange G,et al.Preoperative radiotherapy in elderly patients with rectal cancer. Gastroenterol Clin Biol, 2007, 31(4): 436-441.
[32]
Pasetto LM, Friso ML, Pucciarelli S, et al. Rectal cancer neoadjuvant treatment in elderly patients. Anticancer Res, 2006, 26(5B): 3913-3923.
[33]
Pettersson D, Holm T, Iversen H,et al.Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. British Journal of Surgery, 2012, 99(4): 577-583.
[34]
Pettersson D, Cedermark B, Holm T, et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. British Journal of Surgery, 2010, 97(4): 580-587.
[35]
Pettersson D, Lörinc E, Holm T, et al. Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. British Journal of Surgery, 2015, 102(8): 972-978.
[36]
Ceelen W, Fierens K, Van Nieuwenhove Y, et al. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis. Int J Cancer, 2009, 124(12): 2966-2972.
[37]
Neugut AI, Fleischauer AT, Sundararajan V, et al.Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol, 2002, 20(11): 2643-2650.
[38]
Martijn H, Vulto JC.Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer? Eur J Cancer, 2007, 43(15): 2301-2306.
[39]
Dobie SA, Warren JL, Matthews B, et al. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer, 200, 112(4): 789-799.
[40]
Gérard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol, 2010, 28(10): 1638-1644.
[41]
François E, Azria D, Gourgou-Bourgade S, et al. Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: tolerance and efficacy. Radiother Oncol, 2014, 110(1): 144-149.
[42]
Jiang DM, Raissouni S, Mercer J, et al. Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer. Annals of Oncology, 2015, 6(10): 2102-2106.
[1] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[2] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[3] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[4] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[5] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[6] 李凤仪, 李若凡, 高旭, 张超凡. 目标导向液体干预对老年胃肠道肿瘤患者术后血流动力学、胃肠功能恢复的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 29-32.
[7] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[8] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[9] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[10] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[11] 郭震天, 张宗明, 赵月, 刘立民, 张翀, 刘卓, 齐晖, 田坤. 机器学习算法预测老年急性胆囊炎术后住院时间探索[J]. 中华临床医师杂志(电子版), 2023, 17(9): 955-961.
[12] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[13] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要